Dr. Azzer is a licensed Registered Pharmacist (PharmD, RPh) and Senior Pharmaceutical Consultant advising health systems, biopharmaceutical enterprises, clinical researchers, and healthcare institutions on regulatory affairs, formulary strategy, and medication safety.
As a licensed Registered Pharmacist (PharmD, RPh), Board Certified Pharmacotherapy Specialist (BCPS), and Regulatory Affairs Certified (RAC) professional, Dr. Azzer partners with health systems, clinical research organizations, biopharmaceutical developers, and pharmacy executive leadership. With deep domain knowledge spanning regulatory compliance, P&T formulary optimization, pharmacovigilance, and health economics, Dr. Azzer delivers measurable clinical, operational, and financial outcomes.
Conducting comprehensive GCP/GMP audit readiness assessments, regulatory filings review, and SOP modernization for biopharma sponsors and clinical sites.
Evaluating comparative clinical efficacy and cost-effectiveness models to optimize health-system drug formularies and manage high-cost specialty biologics.
Designing scalable adverse event reporting frameworks and FDA Risk Evaluation and Mitigation Strategies (REMS) to protect patients and ensure ongoing compliance.
"Evidence-based pharmacotherapy and rigorous regulatory governance form the cornerstone of sustainable modern healthcare delivery."
- Dr. Azzer, PharmD, RPh, BCPS (Senior Pharmaceutical Consultant)